Do HIV Disease Progression and HAART Response Vary among Injecting Drug Users in Europe?

This publication has 48 references indexed in Scilit:

• CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients
  AIDS, 2004
• Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS
  International Journal of Epidemiology, 2004
• Predictors of Immunological Failure after Initial Response to Highly Active Antiretroviral Therapy in HIV‐1–Infected Adults: A EuroSIDA Study
  The Journal of Infectious Diseases, 2004
• Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level
  European Journal of Public Health, 2003
• Determinants of survival following HIV-1 seroconversion after the introduction of HAART
  The Lancet, 2003
• Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters
  AIDS, 2003
• Optimal therapy of hepatitis C
  Hepatology, 2002
• Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999
  Sexually Transmitted Infections, 2002
• Methods for estimating the AIDS incubation time distribution when date of seroconversion is censored
  Statistics in Medicine, 2001
• Has the rate of progression to AIDS changed in recent years?
  AIDS, 1997